コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nic alternative modality for prostate cancer suicide gene therapy.
2 d molecular imaging agents targeting HSV1-tk suicide gene therapy.
6 , this cytokine approach was combined with a suicide gene therapy and subcutaneous B16 melanomas were
7 sent the findings on improved techniques for suicide gene therapy and various oncolytic viral therapi
8 ndidate for anti-microbial drug development, suicide-gene therapy, and cell-specific mRNA labeling te
10 x virus type 1 (HSV-1) thymidine kinase (TK) suicide gene therapy as a potential antitumor treatment.
11 this attribute could be exploited in cancer suicide gene therapy by using a lentiviral (LV) vector e
12 ication-competent adenovirus-mediated double-suicide gene therapy can be combined safely with convent
13 hypothesis that the effectiveness of HSV-TK suicide gene therapy can be enhanced by coexpression of
14 deficiencies, chronic granulomatous disease, suicide gene therapy for graft-versus-host disease, vira
15 d HVP22 to enhance Etk/ganciclovir (Etk/GCV) suicide gene therapy for neuroblastomas by GCV cytotoxic
17 ductase enzyme (NTR) has been widely used in suicide gene therapy (GDEPT and ADEPT) applications as a
18 udied antiglioma gene therapy strategies are suicide gene therapy, genetic immunotherapy and oncolyti
19 utic potential of BVP22 and HVP22 in Etk/GCV suicide gene therapy in this tumor system is not due to
21 emonstrate that CID-regulated, caspase-based suicide gene therapy is safe and can inhibit the growth
26 e cell-based, non-viral or viral vectors for suicide gene therapy of cancer make more informed decisi
28 ible to utilize such nucleoside analogues in suicide gene therapy or protein therapy applications tha
29 or obstacle to the successful application of suicide gene therapy strategies that rely on in situ tra
32 evaluated the safety and efficacy of a novel suicide gene therapy that could potentially spare normal
35 with established liver metastases show that suicide gene therapy using TK- vaccinia virus as a vecto
38 est the potential therapeutic efficacy of DT suicide gene therapy, we first developed a DT-resistant
40 In a mouse xenograft model of lung cancer, suicide gene therapy with LV-ARE-TK/GCV was effective co
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。